Skip to main content
logo
Applied Therapeutics, Inc. (APLT)
Feb 3, 2026 - APLT was delisted (reason: acquired by Cycle Pharmaceuticals)
0.1030
0.00 (0.00%)
Inactive · Last trade price on Feb 2, 2026

Applied Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
10.469.99---
Revenue Growth
-89.43%-95.45%----
Gross Profit
10.469.99---
Operating Income
-98.4-104.3-64.54-82.95-105.62-94.47
Net Income
-18.14-105.62-119.76-82.51-105.58-93.96
Earnings Per Share
-0.10-0.76-1.42-2.18-4.12-4.28
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
11.9579.449.930.5880.8296.83
Total Debt
2.52.80.470.891.331.74
Net Cash (Debt)
9.4576.649.4329.6979.4995.09
Net Cash Growth
-90.25%54.97%66.50%-62.65%-16.41%158.29%
Net Cash Per Share
0.070.550.590.783.114.33

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-86.85-84.31-55.17-78.09-90.73-78.21
Free Cash Flow
-86.85-84.31-55.17-78.09-90.73-78.21
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-9850.15%-22922.86%-645.80%---
Pretax Margin
-1815.62%-23214.07%-1198.47%---
Profit Margin
-1815.62%-23214.07%-1198.47%---
FCF Margin
-8693.39%-18528.57%-552.12%---

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
14.93258.2328.45---